Childhood Obesity
Conditions
Brief summary
The aim of this study is to investigate the effect of mobile health nutrition education intervention in the changing of dietary habits and body composition of overweight and obese 8-12 years old children in Sharjah, United Arab Emirates and to compare its effectiveness to paper educational intervention among the same age group. The main questions it aims to answer are: 1. Are there any significant changes in dietary habits, physical activity and body composition among overweight and obese school-age children after three months of mobile health intervention? 2. Is there any significant difference between the effect of smart phone delivered and paper delivered interventions (changes in dietary habits, physical activity and body composition) among overweight and obese school-age children after three months of interventions? 3. Are there any significant changes in the obesity inflammatory panel among overweight and obese school-age children after three months of mobile health intervention? 4. Is there any significant difference in the sustainability of the outcomes between mobile health and paper delivered interventions among overweight and obese school-age children two months after the end of the intervention? 5. Are there any significant changes in nutrition related knowledge among parents of overweight and obese school-age children after three months of intervention? Participants (children with their parents) will be randomly divided into intervention group and control group. Parents of children from the intervention group will receive two text messages/graphics per week about healthy eating and physical activity (PA) on their mobile phones during the intervention period (3 months). While parents in the control group will receive a one-time printed handout containing the same messages at the beginning of the intervention period. Assessment of children's anthropometry, dietary intake and physical activity will be evaluated pre and post intervention and one more time after a two months period of maintenance after the end of the intervention. Parents' nutrition knowledge will be evaluated pre and post intervention only. Also, children salivary obesity markers will be measured at baseline and at the end of the intervention period to explore the effects of the intervention on inflammatory markers associated with obesity.
Interventions
OTHERSmart Phone Education (mhealth)
Nutrition and Health Education module delivered through m-health approach (smart phones)
OTHERPaper Education (conventional)
Nutrition and Health Education module delivered through conventional approach (paper)
Sponsors
University of Sharjah
Universiti Sains Malaysia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
Lab technician who will handle the saliva analysis and the person who will be doing the statistical analysis will be blinded of any data related to the grouping of the participants.
Intervention model description
Participants will be randomly divided into intervention group and control group. intervention group will receive smart phone delivered nutrition education while control group will receive paper delivered nutrition education.
Eligibility
Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No
Inclusion criteria
* Overweight/obese children (over 2 SD based on the WHO Growth Reference (2007)). * Between 8 - 12 years old. * Attending school in Sharjah, UAE.
Exclusion criteria
* Children on a specific diet. * Children who have any chronic diseases. Parents qualify if their children meet the inclusion criteria, they can read and speak in Arabic, they plan to stay in Sharjah for six months from the beginning of the intervention, and they own and use a smart phone.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Body Fat Mass | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Will be measured using a Body Composition Analyzer, and will be measured in Kilograms |
| Fat Free Mass | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Will be measured using a Body Composition Analyzer, and will be measured in Kilograms |
| Weight | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Will be measured using a Body Composition Analyzer, and will be measured in Kilograms |
| Height | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Will be measured using a standing Stadiometer, and will be measured in Centimetres |
| Body Mass Index | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Will be calculated using the weight and height, and will be measured in kg/m\^2 |
| Total Body Water | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Will be measured using a Body Composition Analyzer, and will be measured in Kilograms |
| Parents' Knowledge | twice: before intervention (at 0 months) and after intervention (at 3 months). | Using a valid Nutrition Knowledge Attitude Practice Questionnaire - no scale |
| Children's Dietary Intake | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Using 24 Hours' Diet recall (3 days). |
| Children's Physical Activity | 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months) | Using a valid Physical Activity Questionnaire - no scale |
| Salivary C-Reactive Protein Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Adiponectin (Acrp30) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Complement Factor D (Adipsin) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Interleukin 6 (IL-6) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Interleukin 10 (IL-10) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Leptin (OB) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Resistin Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Plasminogen Activator Inhibitor-1 (Serpin E1 / PAI-1) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
| Salivary Tumour Necrosis Factor alpha (TNF alpha) Concentration | twice: before intervention (at 0 months) and after intervention (at 3 months). | Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex) |
Countries
United Arab Emirates
Outcome results
None listed